LA JOLLA — The Salk Institute, which hosts a National Cancer Institute (NCI)-- designated cancer center and Indivumed GmbH,
a world leading cancer research company today announce a multi-year strategic alliance to secure, preserve and analyze human cancer tissue and annotated clinical data from consenting patients around the world, enabling the most cutting - edge basic and translational research in cancer.
Not exact matches
Tough Mudder isn't curing
cancer, but they do feel they're making the
world a slightly better place by helping people
lead more active lives and connect with each other.
«Through this collaboration with the
cancer community's
leading clinical and pathology experts, thousands of more patients can potentially benefit from the
world's growing body of knowledge about this disease,» said IBM Research and Cognitive Solutions senior vice president John Kelly in a statement.
According to the
World Health Organization (WHO), depression is now the single
leading cause of disability worldwide, ahead of both
cancer and heart disease.
Our Connect Education Workshops feature
world -
leading cancer experts and are available by phone or online
Sian Lewis, Macmillan Clinical
Lead Dietitian at the Velindre
Cancer Centre, discusses the role oncology dietitians play in delivering the world class cancer strategy 2015 —
Cancer Centre, discusses the role oncology dietitians play in delivering the
world class
cancer strategy 2015 —
cancer strategy 2015 — 2020.
Support a multi-year effort
led by
world - class scientists to develop a blood test for earlier detection of breast
cancer when survival rates are the highest, known as the EIF Breast Cancer Biomarker Discovery Pr
cancer when survival rates are the highest, known as the EIF Breast
Cancer Biomarker Discovery Pr
Cancer Biomarker Discovery Project.
Importance Childhood
cancer is a
leading cause of mortality among children and adolescents in the developed
world and the incidence increases by 0.9 % each year.
Approximately 175000
cancer cases are diagnosed annually in children younger than age 15 years worldwide, 1 with an annual increase of around 0.9 % in incidence rate in the developed
world, only partly explained by improved diagnosis and reporting.1, 2 Childhood
cancer is rare and its survival rate has increased significantly over the years owing to advancement in treatment technologies; however, it is still a
leading cause of death among children and adolescents in developed countries, ranking second among children aged 1 to 14 years in the United States, surpassed only by accidents.1, 3 Childhood
cancer is also emerging as a major cause of death in the last few years in Asia, Central and South America, Northwest Africa, and the Middle East, where death rates from preventable communicable diseases are declining.2
Childhood
cancer is a
leading cause of mortality among children and adolescents in the developed
world and the incidence increases by 0.9 % each year.
Childhood
cancer is a
leading cause of mortality among children and adolescents in the developed
world and the incidence rate increases each year.
Over the years, Roswell Park has also become recognized as one of the United States»
leading cancer treatment and research centers, and it recruits physicians and researchers from across the
world to come live and work in the Buffalo area.
Age - related diseases include many of the degenerative diseases that affect billions of people around the
world and are among the
leading causes of death: cardiovascular disease, diabetes, Alzheimer's disease and
cancer.
Despite
leading the
world in pioneering anti-smoking laws,
cancer screening and controlling high blood pressure, the US trails its richer «peer» countries in almost all other measures of health and longevity, says a US National Research Council report published last week.
But a substantial proportion of those in whom treatment is successful still go on to develop the disease, the third
leading cause of
cancer death in the
world.
«Colorectal
cancer is the second most common cause of
cancer deaths [after lung
cancer] in the United States and is an enormous health problem around the
world,» said the study's
lead author, Robert J. Mayer, MD, faculty vice president for academic affairs, medical oncologist and colorectal
cancer researcher at Dana - Farber.
It is the third most common form of
cancer and the second
leading cause of death among
cancers in the Western
world.
New research,
led by University of Southampton biological scientist Dr Hannah Siddle, is aiming to develop an effective vaccine against an infectious
cancer that is eradicating the Tasmanian devil, the
world's largest remaining marsupial carnivore.
«After years of collaboration with some of the
world's
leading prostate
cancer researchers and medical institutions who have studied the scientific and clinical benefits of phi, we are pleased that the test is now available to help physicians and patients with an elevated PSA test result, more accurately detect prostate
cancer2,» said John Blackwood, senior vice president, Chemistry / Immunoassay Business Unit, Beckman Coulter Diagnostics.
Colorectal
cancer (CRC) is the second
leading cause of
cancer death in the Western
world.
Depression alone was the
leading cause of disability in every region of the
world except sub-Saharan Africa, and outranked the death and disability caused by anemia (a sign of malnutrition), heart disease,
cancer, malaria and lung disease.
Because it is so deadly and because the number of new cases is increasing, it is predicted to be the second
leading cause of
cancer deaths in the western
world by 2020, trailing only lung
cancer, he adds.
The results come from analysis of one arm of the UK Collaborative Trial of Ovarian
Cancer Screening (UKCTOCS), the world's largest ovarian cancer screening trial, led by UCL and funded by the Medical Research Council, Cancer Research UK, Department of Health and The Eve A
Cancer Screening (UKCTOCS), the
world's largest ovarian
cancer screening trial, led by UCL and funded by the Medical Research Council, Cancer Research UK, Department of Health and The Eve A
cancer screening trial,
led by UCL and funded by the Medical Research Council,
Cancer Research UK, Department of Health and The Eve A
Cancer Research UK, Department of Health and The Eve Appeal.
Martin sees disturbing parallels between the cultural representations of people who fall by the wayside in the
world of work — through unemployment, «deskilling» or lack of training — and those who fall ill as a result of «inferior» immune responses,
leading to AIDS,
cancer or a host of other diseases.
As part of their
cancer prevention efforts, leading cancer organizations, such as the American Cancer Society (ACS) and the World Cancer Research Fund / American Institute for Cancer Research (WCRF / AICR) have published recommendations on diet and physical act
cancer prevention efforts,
leading cancer organizations, such as the American Cancer Society (ACS) and the World Cancer Research Fund / American Institute for Cancer Research (WCRF / AICR) have published recommendations on diet and physical act
cancer organizations, such as the American
Cancer Society (ACS) and the World Cancer Research Fund / American Institute for Cancer Research (WCRF / AICR) have published recommendations on diet and physical act
Cancer Society (ACS) and the
World Cancer Research Fund / American Institute for Cancer Research (WCRF / AICR) have published recommendations on diet and physical act
Cancer Research Fund / American Institute for
Cancer Research (WCRF / AICR) have published recommendations on diet and physical act
Cancer Research (WCRF / AICR) have published recommendations on diet and physical activity.
The WHO study, one of a collection of articles in a special issue of the journal devoted to women's health beyond reproduction, found that the
leading causes of death of women aged 50 years and older worldwide are cardiovascular disease (heart disease and stroke) and
cancers, but that in developing countries these deaths occur at earlier ages than in the rich
world.
«The researchers now plan to team up with other
world -
leading experts in
cancer signalling based in Manchester including Professor Nic Jones, Director of MCRC and Cancer Research UK Chief Scientist who heads the Cell Regulation Laboratory, which studies how cells respond to sudden adverse changes in their surroundings, known as environmental s
cancer signalling based in Manchester including Professor Nic Jones, Director of MCRC and
Cancer Research UK Chief Scientist who heads the Cell Regulation Laboratory, which studies how cells respond to sudden adverse changes in their surroundings, known as environmental s
Cancer Research UK Chief Scientist who heads the Cell Regulation Laboratory, which studies how cells respond to sudden adverse changes in their surroundings, known as environmental stress.
«Similar assumptions would
lead to estimates of many thousands more
cancers throughout the
world because fall - out from the atmospheric tests was distributed globally,» he notes.
FORT LAUDERDALE / DAVIE, Fla. —
Leading faculty members from the Nova Southeastern University (NSU) College of Allopathic Medicine (M.D. College) are scheduled to present their research related to advancing new approaches to
cancer immunotherapy and regenerative medicine at the 2018
World Stem Cell Summit (WSCS).
Today, his discoveries continue to
lead his lab and others around the
world in developing genetic tests, diagnostics and therapies for
cancer.
In addition to Amgen's work to improve
cancer patient treatment through science - based innovation, CRI will also recognize the company's commitment to the broader scientific and patient communities, both through its support of CRI's Cancer Immunotherapy Month education and awareness initiative, and for its support of the CRI - CIMT - EATI - AACR International Cancer Immunotherapy Conference, a joint program of four cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy res
cancer patient treatment through science - based innovation, CRI will also recognize the company's commitment to the broader scientific and patient communities, both through its support of CRI's
Cancer Immunotherapy Month education and awareness initiative, and for its support of the CRI - CIMT - EATI - AACR International Cancer Immunotherapy Conference, a joint program of four cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy res
Cancer Immunotherapy Month education and awareness initiative, and for its support of the CRI - CIMT - EATI - AACR International
Cancer Immunotherapy Conference, a joint program of four cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy res
Cancer Immunotherapy Conference, a joint program of four
cancer research organizations that convenes world - leading scientists to discuss the latest in cancer immunology and immunotherapy res
cancer research organizations that convenes
world -
leading scientists to discuss the latest in
cancer immunology and immunotherapy res
cancer immunology and immunotherapy research.
The
Cancer Research Institute (CRI), established in 1953, is the world's leading nonprofit organization dedicated exclusively to transforming cancer patient care by advancing scientific efforts to develop new and effective immune system - based strategies to prevent, diagnose, treat, and eventually cure all ca
Cancer Research Institute (CRI), established in 1953, is the
world's
leading nonprofit organization dedicated exclusively to transforming
cancer patient care by advancing scientific efforts to develop new and effective immune system - based strategies to prevent, diagnose, treat, and eventually cure all ca
cancer patient care by advancing scientific efforts to develop new and effective immune system - based strategies to prevent, diagnose, treat, and eventually cure all
cancers.
Lung
cancer is the
leading cause of
cancer - related deaths in the
world, and non-small cell lung
cancer accounts for > 75 % of all lung
cancer cases.
On October 2, 2015, the FDA approved the immunotherapy drug pembrolizumab (Keytruda ®), made by Merck, as second - line treatment for patients with lung
cancer, the
leading cause of
cancer - related death in the U.S. and the
world.
The Clinical Accelerator network includes approximately 80 of the
world's
leading physician - scientists with expertise in tumor immunology and
cancer immunotherapy clinical trials, immune monitoring, and correlative research.
St. Jude Children's Research Hospital is
leading the way the
world understands, treats and defeats childhood
cancer and other life - threatening diseases.
About Johns Hopkins Kimmel
Cancer Center Since its opening in 1973, the Johns Hopkins Kimmel Cancer Center has led the world in deciphering the mechanisms of cancer and new ways to tre
Cancer Center Since its opening in 1973, the Johns Hopkins Kimmel
Cancer Center has led the world in deciphering the mechanisms of cancer and new ways to tre
Cancer Center has
led the
world in deciphering the mechanisms of
cancer and new ways to tre
cancer and new ways to treat it.
The hepatitis B virus, which chronically infects more than 240 million people worldwide, causes cirrhosis and is the
world's
leading cause of liver
cancer.
Dr. Inder M. Verma is an American
Cancer Society Professor in the Laboratory of Genetics at the Salk Institute in La Jolla, California, and one of the
world's
leading authorities on the development and use of engineered viruses for gene therapy.
Dr. Verma is one of the
world's
leading authorities in
cancer biology.
These are the words of a core statement from a study, recently published in the highly respected journal «The Lancet Oncology», which was set up based on collaboration between the
world's
leading centres for the research and treatment of prostate
cancer.
About The Ohio State University Comprehensive
Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and trea
Cancer Center — Arthur G. James
Cancer Hospital and Richard J. Solove Research Institute The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and trea
Cancer Hospital and Richard J. Solove Research Institute The Ohio State University Comprehensive
Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and trea
Cancer Center — Arthur G. James
Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and trea
Cancer Hospital and Richard J. Solove Research Institute strives to create a
cancer - free world by integrating scientific research with excellence in education and patient - centered care, a strategy that leads to better methods of prevention, detection and trea
cancer - free
world by integrating scientific research with excellence in education and patient - centered care, a strategy that
leads to better methods of prevention, detection and treatment.
Gastric adenocarcinoma is the second
leading cause of
cancer - related death in the
world, and Helicobacter pylori, a bacterial species that persistently colonizes the human stomach and induces chronic gastritis, is the strongest known risk factor for this malignancy.
Staffed by some of the
world's
leading experts in the field, the Ludwig Center for
Cancer Immunotherapy is streamlining the translation of basic science discoveries made in a variety of
cancers toward patient care.
Although pediatric
cancer is rare, it's the
leading cause of disease - related death among children who survive past infancy (in the Western
world).
We also co-fund 18 Experimental
Cancer Medicine Centres (ECMCs), which bring world - leading doctors, research nurses and technical staff together to develop and test new cancer treat
Cancer Medicine Centres (ECMCs), which bring
world -
leading doctors, research nurses and technical staff together to develop and test new
cancer treat
cancer treatments.
About the
Cancer Research Institute The Cancer Research Institute (CRI), established in 1953, is the world's leading nonprofit organization dedicated exclusively to immuno - oncology, also called cancer immunoth
Cancer Research Institute The
Cancer Research Institute (CRI), established in 1953, is the world's leading nonprofit organization dedicated exclusively to immuno - oncology, also called cancer immunoth
Cancer Research Institute (CRI), established in 1953, is the
world's
leading nonprofit organization dedicated exclusively to immuno - oncology, also called
cancer immunoth
cancer immunotherapy.
Nicola Blackwood, Minister for Public Health and Innovation, said: «We want to
lead the
world in fighting
cancer.
Guided by a
world - renowned Scientific Advisory Council that includes three Nobel laureates and 26 members of the National Academy of Sciences, CRI has invested $ 336 million in support of research conducted by immunologists and tumor immunologists at the
world's
leading medical centers and universities, and has contributed to many of the key scientific advances that demonstrate the potential for immunotherapy to change the face of
cancer treatment.
With more than 30,000 members, ASCO is the
world's
leading professional organization representing physicians who care for people with
cancer.